Advanced Glycation End Products and Receptors in Fuchs' Dystrophy Corneas Undergoing Descemet's Stripping with Endothelial Keratoplasty

Ophthalmology

Volumn 114, Issue 8, 2007, Pages 1453-1460

  Wang, Zhiyou ^a   Handa, James T ^a   Green, W Richard ^a   Stark, Walter J ^a   Weinberg, Robert S ^a   Jun, Albert S ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; EOSIN; GALECTIN 3; HEMATOXYLIN;

AGED; ARTICLE; CLINICAL ARTICLE; CONGENITAL CORNEA DYSTROPHY; CONTROLLED STUDY; CORNEA THICKNESS; CORRELATION ANALYSIS; DESCEMET MEMBRANE; DESCEMET STRIPPING WITH ENDOTHELIAL KERATOPLASTY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FUCHS ENDOTHELIAL CORNEAL DYSTROPHY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOPLASTY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; APOPTOSIS; CORNEAL TRANSPLANTATION; DESCEMET MEMBRANE; ENDOTHELIUM, CORNEAL; FEMALE; FUCHS' ENDOTHELIAL DYSTROPHY; GALECTIN 3; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSPECTIVE STUDIES; RECEPTORS, IMMUNOLOGIC; TISSUE DONORS;

EID: 34547167873     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.10.049     Document Type: Article

References (40)

1. Corneal dystrophy, Fuchs endothelial, 1; FECD1. Online-Mendelian-Inheritance-in-Man (OMIM) [database online]. Updated June 6, 2006. Available at: http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=136800. Accessed June 22, 2006.
2. Waring III G.O., Bourne W.M., Edelhauser H.F., and Kenyon K.R. The corneal endothelium: normal and pathologic structure and function. Ophthalmology 89 (1982) 531-590
3. Krachmer J.H., Purcell Jr. J.J., Young C.W., and Bucher K.D. Corneal endothelial dystrophy: a study of 64 families. Arch Ophthalmol 96 (1978) 2036-2039
4. Biswas S., Munier F.L., Yardley J., et al. Missense mutations in COL8A2, the gene encoding the alpha2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum Mol Genet 10 (2001) 2415-2423
5. Gottsch J.D., Sundin O.H., Liu S.H., et al. Inheritance of a novel COL8A2 mutation defines a distinct early-onset subtype of Fuchs corneal dystrophy. Invest Ophthalmol Vis Sci 46 (2005) 1934-1939
6. Borderie V.M., Baudrimont M., Vallee A., et al. Corneal endothelial cell apoptosis in patients with Fuchs' dystrophy. Invest Ophthalmol Vis Sci 41 (2000) 2501-2505
7. Li Q.J., Ashraf M.F., Shen D.F., et al. The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch Ophthalmol 119 (2001) 1597-1604
8. Szentmary N., Szende B., and Suveges I. Epithelial cell, keratocyte, and endothelial cell apoptosis in Fuchs' dystrophy and in pseudophakic bullous keratopathy. Eur J Ophthalmol 15 (2005) 17-22
9. Gottsch J.D., Bowers A.L., Margulies E.H., et al. Serial analysis of gene expression in the corneal endothelium of Fuchs' dystrophy. Invest Ophthalmol Vis Sci 44 (2003) 594-599
10. Buddi R., Lin B., Atilano S.R., et al. Evidence of oxidative stress in human corneal diseases. J Histochem Cytochem 50 (2002) 341-351
11. Melles G.R., Eggink F.A., Lander F., et al. A surgical technique for posterior lamellar keratoplasty. Cornea 17 (1998) 618-626
12. Terry M.A., and Ousley P.J. Deep lamellar endothelial keratoplasty in the first United States patients: early clinical results. Cornea 20 (2001) 239-243
13. Terry M.A., and Ousley P.J. Small-incision deep lamellar endothelial keratoplasty (DLEK): six-month results in the first prospective clinical study. Cornea 24 (2005) 59-65
14. Terry M.A., and Ousley P.J. Deep lamellar endothelial keratoplasty: visual acuity, astigmatism, and endothelial survival in a large prospective series. Ophthalmology 112 (2005) 1541-1548
15. Melles G.R., Wijdh R.H., and Nieuwendaal C.P. A technique to excise the descemet membrane from a recipient cornea (descemetorhexis) [sic]. Cornea 23 (2004) 286-288
16. Price Jr. F.W., and Price M.O. Descemet's stripping with endothelial keratoplasty in 200 eyes: early challenges and techniques to enhance donor adherence. J Cataract Refract Surg 32 (2006) 411-418
17. Brownlee M., Cerami A., and Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318 (1988) 1315-1321
18. Wautier J.L., and Schmidt A.M. Protein glycation: a firm link to endothelial cell dysfunction. Circ Res 95 (2004) 233-238
19. Barile G.R., Pachydaki S.I., Tari S.R., et al. The RAGE axis in early diabetic retinopathy. Invest Ophthalmol Vis Sci 46 (2005) 2916-2924
20. Hammes H.P., Hoerauf H., Alt A., et al. N(epsilon)(carboxymethyl)lysin and the AGE receptor RAGE colocalize in age-related macular degeneration. Invest Ophthalmol Vis Sci 40 (1999) 1855-1859
21. Howes K.A., Liu Y., Dunaief J.L., et al. Receptor for advanced glycation end products and age-related macular degeneration. Invest Ophthalmol Vis Sci 45 (2004) 3713-3720
22. Ramasamy R., Vannucci S.J., Yan S.S., et al. Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation. Glycobiology 15 (2005) 16R-28R
23. Ramasamy R., Yan S.F., and Schmidt A.M. Methylglyoxal comes of AGE. Cell 124 (2006) 258-260
24. Sady C., Khosrof S., and Nagaraj R. Advanced Maillard reaction and crosslinking of corneal collagen in diabetes. Biochem Biophys Res Commun 214 (1995) 793-797
25. Wautier M.P., Chappey O., Corda S., et al. Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 280 (2001) E685-E694
26. Singh R., Barden A., Mori T., and Beilin L. Advanced glycation end-products: a review. Diabetologia 44 (2001) 129-146
27. Chen H.Y., Liu F.T., and Yang R.Y. Roles of galectin-3 in immune responses. Arch Immunol Ther Exp (Warsz) 53 (2005) 497-504
28. Nakahara S., Oka N., and Raz A. On the role of galectin-3 in cancer apoptosis. Apoptosis 10 (2005) 267-275
29. McDowell E.M. Fixation and processing. In: Trump B.F., and Jones R.T. (Eds). Diagnostic Electron Microscopy Vol. 1 (1978), Wiley, New York 113-139
30. Yuen H.K., Rassier C.E., Jardeleza M.S., et al. A morphologic study of Fuchs dystrophy and bullous keratopathy. Cornea 24 (2005) 319-327
31. Barthel L.K., and Raymond P.A. Improved method for obtaining 3-microns cryosections for immunocytochemistry. J Histochem Cytochem 38 (1990) 1383-1388
32. Yamada Y., Ishibashi K., Ishibashi K., et al. The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas. Exp Eye Res 82 (2006) 840-848
33. Kaji Y., Usui T., Oshika T., et al. Advanced glycation end products in diabetic corneas. Invest Ophthalmol Vis Sci 41 (2000) 362-368
34. Murphy C., Alvarado J., and Juster R. Prenatal and postnatal growth of the human Descemet's membrane. Invest Ophthalmol Vis Sci 25 (1984) 1402-1415
35. Cheng R., Lin B., and Ortwerth B.J. Rate of formation of AGEs during ascorbate glycation and during aging in human lens tissue. Biochim Biophys Acta 1587 (2002) 65-74
36. Lee K.W., Mossine V., and Ortwerth B.J. The relative ability of glucose and ascorbate to glycate and crosslink lens proteins in vitro. Exp Eye Res 67 (1998) 95-104
37. Haung W., Koralewska-Makar A., Bauer B., and Akesson B. Extracellular glutathione peroxidase and ascorbic acid in aqueous humor and serum of patients operated on for cataract. Clin Chim Acta 261 (1997) 117-130
38. Kaji Y., Amano S., Usui T., et al. Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells. Invest Ophthalmol Vis Sci 44 (2003) 521-528
39. Yan S.D., Schmidt A.M., Anderson G.M., et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269 (1994) 9889-9897
40. Krzeslak A., and Lipinska A. Galectin-3 as a multifunctional protein. Cell Mol Biol Lett 9 (2004) 305-328